When a runner reports pain, the conversation often becomes binary: keep going or stop. Research on Achilles tendinopathy (Silbernagel et al., 2007) points to a middle ground. Runners who kept training within an agreed pain-monitoring model improved just as much as those who rested. That shifts the question from “run or rest?” to “how much?” OnTracx connects biomechanical running load with reported pain and effort after every run. That gives physios and coaches the insight to adjust the plan while a setback is still small. From setbacks to comebacks. #sportsphysiotherapy #returntorun #runninginjuries #loadmanagement #sportsscience

On this #OneHealthDay, the ongoing Bundibugyo #Ebola outbreak in the DRC is a reminder of why outbreak response needs to look beyond human health data. Most emerging infectious diseases are zoonotic: pathogens circulate in animals before spilling over to humans. Data infrastructure for preparedness and response has to reflect those interactions. The Ministry of Health of the DRC is applying an integrated approach to the response, building on the One Health platform developed during the Mpox outbreak. Bluesquare supports this work on two fronts: 👉 Connecting siloed systems. Human, animal and environmental data are harmonized into a single platform with a standardized database; 👉 Building multi-sector data products. Dashboards, automated reports and risk maps give every sector a consolidated view of the outbreak. #OneHealthDay #Epidemiology #DigitalHealth #DRC Gaspard Pairault and Grégoire Lurton Gilbert Ngonga Emmanuel IBANDA MVUNZI Guillaume Hansart

We are delighted and proud to read how the Histolog Scanner contributed to patient care at University College London Hospitals NHS Foundation Trust (UCLH). Congratulations to Professor Greg Shaw, Professor of Urology and Lead for robotic urology, and to consultant pathologists Anna Silvanto, Aiman Haider, Alex Freeman and Aswathy Menon. Your expertise and teamwork turn Histolog Scanner images into additional information for the surgical team, while each patient is in surgery. It is inspiring to see clinicians come together with so much care for the people they serve. We are deeply grateful to contribute to your work for patients. Warmest congratulations to you and the whole team. FOR AUDIENCES OUTSIDE THE UNITED STATES ONLY. This content is not intended for U.S. audiences and includes claims or indications that differ from the U.S.-cleared labeling for the Histolog Scanner. For the U.S.-cleared Indication for Use and Important Safety Information, visit: lnkd.in/eggR2GfZ #Histolog #HistologScanner #SamanTree #SamanTreeMedical Olivier Delporte Michael Planck Schøn Hansen Ben Hennessy Tom Engels Eloi SERVOUSE Jozef Tanczos Camille Eloy Etienne Shaffer Dr. Tina Manoharan Marilda Gougou

🎤 MEET THE SPEAKERS | AI and the Future of European Frontier Research and Innovation in Health On 25 November 2026, the I3h Institute will bring together experts from academia, the health innovation ecosystem and European institutions to explore the future of AI-driven research and innovation in Europe. 🔎 Meet our speakers: - Hugues Bersini: Professor of Artificial Intelligence at Université libre de Bruxelles and FARI - AI for the Common Good Institute - Niklas Blomberg: Executive Director of the Innovative Health Initiative (IHI) - Yves-Alexandre de Montjoye: Professor at Imperial College London - Mathias Dewatripont: Kurgan van-Hentenryck Chair and I3h Institute President - Alain Fischer: Physician scientist and Emeritus Professor at Collège de France - Serge Goldman: Physician scientist and Emeritus Professor at Université libre de Bruxelles - Tom Lenaerts: Professor at Université libre de Bruxelles and FARI - AI for the Common Good Institute - Damien Neven: Professor at Geneva Graduate Institute and former Chief Economist, DG-Competition, European Commission - Georges Siotis: Professor at Universidad Carlos III de Madrid & I3h Institute - Aneta Tyszkiewicz: Associate Director, Digital & Data for Science Policy & Regulatory Affairs, EFPIA - European Federation of Pharmaceutical Industries and Associations - Henry Taysom: Senior director strategy, Relation Therapeutics, and expert resident London Institute for Healthcare Engineering - Ludivine Verboogen & Romain Alderweireldt: Co-founders, 101 Genomes Foundation From cutting-edge research to European policy and patient-driven innovation, discover the diverse perspectives shaping the future of AI in health. 📅 25 November 2026 - 9.30 am - 5.30 pm 📍 Residence Palace, Brussels 🔗Register here: lnkd.in/eqJr4JTk #ArtificialIntelligence #HealthInnovation #FrontierResearch #EuropeanResearch #I3h

Officina, ziekenhuis, industrie, academie, klinische studies. Op het Apothekersbal is elke apotheker welkom. Ook wie een minder klassiek pad koos. Want je diploma kan heel wat meer dan je misschien denkt. Onze partner ChipSoft België is daar het bewijs van. Zij ontwikkelen HiX, het elektronisch patiëntendossier dat in heel wat ziekenhuizen draait. En wie zit mee aan de knoppen? Apothekers natuurlijk! Je kan dit zelf gaan bekijken tijdens een exclusief bedrijfsbezoek in Berchem. Pauline Voorspoels en Kenneth Maes, allebei apotheker van opleiding, vertellen hoe zij hun farmaceutische kennis inzetten in de digitale zorg. 🕘 Ontvangst met eten om 19u, einde rond 21u30. 📆 Dinsdag 17 november 📍ChipSoft, Borsbeeksebrug 30, Berchem. Inschrijven gaat zonder voorschrift: stuur een mailtje met je naam naar recruitment_antwerpen@chipsoft.com. Kom je met de wagen? Vraag er meteen een gratis parkeerplaats bij. Zelf niet op zoek, maar ken je een collega die al een tijdje twijfelt? Stuur dit gerust door. En heb jij zelf een atypisch apothekersberoep? Dan zien we je graag op 20 maart 2027 in Ternat, samen met al jouw fijne collega’s 😉 #Apothekersbal #Apotheker #ChipSoft #DigitaleZorg Samen met ChipSoft België - Inge Winters - Lotte Schijvens

One week until The Rise of the “Data-Pilot.” Most trial teams aren’t short on data or dashboards. What they’re missing is a fast answer to three questions: which signals matter, who should act, and when. On Nov 10, Richard Young, Zabir Macci and Juan Munoz-Pujol will show how an AI-powered Clinical Data Control Tower answers those questions, and what changes for the Data Managers running it. → The shift from data review to directed intelligence → How APIs, RBQM and AI connect eSource, labs and EDC into one decision layer → Where human oversight fits as AI agents take on more of the work Save your spot today: hubs.ly/Q04D5vC10 #ClinicalDataManagement #ClinicalTrials #RBQM #AIinClinicalTrials #ClinicalResearch

One week until The Rise of the “Data-Pilot.” Most trial teams aren’t short on data or dashboards. What they’re missing is a fast answer to three questions: which signals matter, who should act, and when. On Nov 10, Richard Young, Zabir Macci and Juan Munoz-Pujol will show how an AI-powered Clinical Data Control Tower answers those questions, and what changes for the Data Managers running it. → The shift from data review to directed intelligence → How APIs, RBQM and AI connect eSource, labs and EDC into one decision layer → Where human oversight fits as AI agents take on more of the work Save your spot today: hubs.ly/Q04D5vC10 #ClinicalDataManagement #ClinicalTrials #RBQM #AIinClinicalTrials #ClinicalResearch

Yesterday evening in Paris, Revatis supported this nice event. A good opportunity to present our last innovation : the MAPS kit (Mechanical Activated Platelets Secretome). A promising autologous ortho-biologics for pets and horses. #revatis #axovet #orthobiologics #regenerativemedicine #horse #dog #osteoarthritis

🎬 𝐍𝐞𝐱𝐭 𝐋𝐢𝐯𝐞 𝐈𝐁𝐀 𝐖𝐞𝐛𝐢𝐧𝐚𝐫, 𝐦𝐞𝐞𝐭 𝐭𝐡𝐞 𝐬𝐩𝐞𝐚𝐤𝐞𝐫𝐬 Let us introduce the renowned experts in the field who will share their insights during our next live webinar: Health Technology Assessment in Nuclear Medicine: From Evidence Generation to Patient Access. 🎙️Health technology assessment in nuclear medicine: Challenges and opportunities in Europe, by Prof Dr Nadia Withofs, Nuclear Medicine Physician 🏢Institut de Cancérologie Arsène Burny (ICAB), CHU de Liège, Belgium 🎙️Health economics: From Clinical Value to Economic Value, by Prof Dr Lieven Annemans, MSc Health, PhD Econ, Senior Full Professor of Health Economics 🏢Ghent University, Belgium 🎙️What does HTA mean for industry? by Dr Konrade von Bremen, Vice President and Treasurer 🏢Nuclear Medicine Europe (NMEU), Switzerland 🎙️𝐋𝐢𝐯𝐞 𝐐&𝐀 𝐬𝐞𝐬𝐬𝐢𝐨𝐧, moderated by Mrs Cristiana Gameiro, PhD, IBA Fellow & Domain Expert in radiochemistry 🏢 IBA, Belgium 👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 lnkd.in/eASNQD86 📅 November 17ᵗʰ, 2.00 PM (CET Brussels) Can't join us live? Register anyway — you'll get access later to the webinar on-demand. #HTA #HealthTechnologyAssessment #IBAwebinar

Kasai and Kasai-Oriental are among the DRC provinces with the highest numbers of children who have never received a single vaccine dose, according to Gavi, the Vaccine Alliance. Bluesquare received a US$8.8 million multi-year grant from GiveWell to help increase immunization coverage in Kasai province. Starting in October 2026, the 3.5-year project will operate under the leadership of the national Expanded Program on Immunization (PEV RDC), Kasai's provincial health authorities and provincial EPI antennas, in collaboration with EUP FASS. How the approach works: ➡️ More than 100 health areas contracted; ➡️ A mix of interventions adapted to each area's context; ➡️ Funding tied to verified results. The goal: an increase of 10 percentage points or more in immunization coverage across the targeted health areas. Bluesquare's contribution is one of several vaccination programs GiveWell has funded in the DRC. 🔗 Learn more: lnkd.in/e4GXYFgP  #Immunization #ZeroDose #DRC #GlobalHealth

Un virus chez un animal peut finir aux urgences d’un hôpital. Plus de 60 % des maladies infectieuses émergentes ont une origine animale. Aujourd’hui, journée mondiale One Health : voici l’idée, simplement. Une maladie ne s’arrête pas à la clôture d’un élevage. Elle ne s’arrête pas non plus à la porte d’un hôpital. Alors pourquoi organiser la santé comme si chaque secteur travaillait sur une île, avec ses propres données, ses propres réflexes et rarement le même interlocuteur en face ? One Health répond à cette question. Concrètement, cela donne des médecins, des vétérinaires et des spécialistes de l’environnement qui échangent plus tôt : sur les zoonoses, la résistance aux antimicrobiens, la sécurité de l’alimentation ou encore la qualité de l’eau et de l’air. Le digital a un rôle à jouer. Il peut faire circuler l’information entre des mondes qui ne partagent pas toujours les mêmes outils. C’est précisément le sujet de notre symposium One Digital Health, le 24 novembre à Namur : comment le digital connecte la santé humaine, animale et environnementale. Si vous souhaitez en découvrir davantage sur le sujet, inscrivez-vous ici : lnkd.in/et62pEvt

Un virus chez un animal peut finir aux urgences d’un hôpital. Plus de 60 % des maladies infectieuses émergentes ont une origine animale. Aujourd’hui, journée mondiale One Health : voici l’idée, simplement. Une maladie ne s’arrête pas à la clôture d’un élevage. Elle ne s’arrête pas non plus à la porte d’un hôpital. Alors pourquoi organiser la santé comme si chaque secteur travaillait sur une île, avec ses propres données, ses propres réflexes et rarement le même interlocuteur en face ? One Health répond à cette question. Concrètement, cela donne des médecins, des vétérinaires et des spécialistes de l’environnement qui échangent plus tôt : sur les zoonoses, la résistance aux antimicrobiens, la sécurité de l’alimentation ou encore la qualité de l’eau et de l’air. Le digital a un rôle à jouer. Il peut faire circuler l’information entre des mondes qui ne partagent pas toujours les mêmes outils. C’est précisément le sujet de notre symposium One Digital Health, le 24 novembre à Namur : comment le digital connecte la santé humaine, animale et environnementale. Si vous souhaitez en découvrir davantage sur le sujet, inscrivez-vous ici : lnkd.in/et62pEvt

Kasai and Kasai-Oriental are among the DRC provinces with the highest numbers of children who have never received a single vaccine dose, according to Gavi, the Vaccine Alliance. Bluesquare received a US$8.8 million multi-year grant from GiveWell to help increase immunization coverage in Kasai province. Starting in October 2026, the 3.5-year project will operate under the leadership of the national Expanded Program on Immunization (PEV RDC), Kasai's provincial health authorities and provincial EPI antennas, in collaboration with EUP FASS. How the approach works: ➡️ More than 100 health areas contracted; ➡️ A mix of interventions adapted to each area's context; ➡️ Funding tied to verified results. The goal: an increase of 10 percentage points or more in immunization coverage across the targeted health areas. Bluesquare's contribution is one of several vaccination programs GiveWell has funded in the DRC. 🔗 Learn more: lnkd.in/e4GXYFgP #Immunization #ZeroDose #DRC #GlobalHealth

Discover. Learn. Get Inspired. Join AGFA HealthCare at #SIRM2026 and embark on a learning journey designed for radiologists, imaging leaders, and healthcare IT professionals looking to stay ahead of the latest innovations in medical imaging. Throughout the congress, our Expert-Led Educational Sessions at Booth B58 will explore topics including #EnterpriseImaging, #RIS, #AI, #Cloud innovation, structured reporting, workflow optimization, and the future of connected #imaging. Together with customers and Amazon Web Services (AWS) and AGFA HealthCare experts, discover practical experiences, lessons learned, and innovative approaches that are transforming clinical workflows and helping imaging organizations deliver greater value. 👉RIS Elefante & Structured Reports – Thursday, November 5, 3:30 PM, Roberto Giorgi – AGFA HealthCare 👉AWS: Enabling Innovation in Imaging – Friday, November 6, 11:30 AM, Fabrizio Discenza – AWS 👉Hanging Protocols: From Setup to Success – Friday, November 6, 2:30 PM, Elena Conte – AGFA HealthCare 👉AI That Creates Value: Two Years of Innovation and Results at ASL Roma 2 – Friday, November 6, 4:30 PM, Dr. Alberto Di Filippo – ASL Roma 2 👉Streaming: Less Waiting. More Speed. A New Diagnostic Experience – Saturday, November 7, 10:00 AM, Marta Barberis – AGFA HealthCare 👉Beyond Pixel AI – Designing AI Around the Radiologist – Saturday, November 7, 12:30 PM, Roberto Guarnieri – AGFA HealthCare Visit AGFA HealthCare at SIRM Booth B58, 5-8 November 2026 | Milan. Book your Enterprise Imaging and RIS demo today and discover the power of radiology. okt.to/Pa4A3M Meet our Italian Team at SIRM 2026: Davide Fumagalli, Andrea Polticchia, Marco Arcelloni, Renato Iaccarino. #EmpowerImaging

How can imaging data guide quality assurance and practical improvement? Join Qaelum for From Monitoring to Action: Quality Assurance in Mammography and CT, with two speakers sharing examples from their work: • Elizabeth Keavey, Principal Medical Physicist at BreastCheck, National Screening Service, Ireland, will explore remote quality monitoring and dosimetry in breast screening. • Hannah Renshall, Trainee Clinical Scientist at Betsi Cadwaladr University Health Board, UK, will discuss CT clinical audits using Qaelum DOSE and subsequent MDT collaboration on healthboard-wide training. There will be time for your questions in a live Q&A with both speakers. 17 November 2026 · 15:00–16:00 CET · Online via Zoom Read more and register: lnkd.in/e43x5_zp #MedicalPhysics #Radiology #Mammography #QualityAssurance

After Philadelphia Eagles quarterback Jalen Hurts was diagnosed with a blood clot, Elsevier’s Complete Anatomy was featured on ABC News’ Doctor’s Note to explain blood clots and how they affect the body. With detailed 3D anatomy visuals, Complete Anatomy makes complex medical concepts easier to see and understand. Learn more: bit.ly/4A45Y7l Watch the segment: bit.ly/3V2QzW4 #CompleteAnatomy #Healthcare #Elsevier #Anatomy

Can we turn recurrence reduction into a long-term survival benefit in early breast cancer? The latest 6️⃣ year NATALEE results offer encouraging evidence that we may be moving closer. lnkd.in/ee-QeNPE Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with high-risk HR+/HER2– early breast cancer: Six-year follow-up of the NATALEE trial The prespecified 6-year NATALEE analysis reinforces the long-term benefit of adding ribociclib to a nonsteroidal aromatase inhibitor 💊 (NSAI) in HR+/HER2– early #BreastCancer . ➡️ Overall survival numerically favored ribociclib, with a 2.1% absolute improvement, alongside a 5.3% improvement in invasive disease-free survival. ➡️Recurrence-related outcomes remained consistently positive, benefits persisted after treatment completion, and no new safety signals emerged, supporting its role in adjuvant treatment strategies. Dennis Slamon Gabriel Hortobagyi Denise Yardley Aditya Bardia Chia Stephen Seock-Ah Im Sherene Loi sara hurvitz Peter Fasching

🫁 𝐇𝐨𝐰 𝐝𝐨𝐞𝐬 𝐑𝐄𝐓 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐟𝐢𝐭 𝐢𝐧𝐭𝐨 𝐲𝐨𝐮𝐫 𝐩𝐞𝐫𝐢𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐩𝐚𝐭𝐡𝐰𝐚𝐲 𝐟𝐨𝐫 𝐫𝐞𝐬𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐍𝐒𝐂𝐋𝐂? During #LungCancerAwarenessMonth, we highlight the importance of advancing lung cancer care as timely treatment decisions and access to molecular insights remain critical. In resectable NSCLC, 𝐬𝐩𝐞𝐞𝐝 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 as much as in advanced disease. Long waiting times between diagnosis and surgery have been associated with worse overall survival, with a time to treatment beyond 33 days linked to a >30% higher mortality risk in stage II disease*. Meanwhile, the 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 in early-stage NSCLC continues to evolve. In the phase 3 LIBRETTO-432 trial, adjuvant selpercatinib in resected stage IB–IIIA RET fusion-positive NSCLC improved 2-year event-free survival to 91.5%, versus 61.1% with placebo**. 💡 With these findings, 𝐑𝐄𝐓 𝐣𝐨𝐢𝐧𝐬 𝐄𝐆𝐅𝐑 𝐚𝐧𝐝 𝐀𝐋𝐊 𝐚𝐦𝐨𝐧𝐠 𝐭𝐡𝐞 𝐭𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 𝐛𝐞𝐢𝐧𝐠 𝐞𝐱𝐩𝐥𝐨𝐫𝐞𝐝 𝐨𝐫 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝 𝐢𝐧 𝐞𝐚𝐫𝐥𝐲-𝐬𝐭𝐚𝐠𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞. The 𝐈𝐝𝐲𝐥𝐥𝐚™ 𝐄𝐆𝐅𝐑 𝐌𝐮𝐭𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐬𝐭 𝐚𝐧𝐝 𝐈𝐝𝐲𝐥𝐥𝐚™ 𝐆𝐞𝐧𝐞𝐅𝐮𝐬𝐢𝐨𝐧 𝐏𝐚𝐧𝐞𝐥 cover EGFR, ALK and RET directly from FFPE tissue, with results in only 3 hours, to inform multidisciplinary discussion on neoadjuvant or adjuvant treatment. 🔗 Learn more: lnkd.in/efUkFfaZ #Biocartis #Idylla #EGFR #ALK #RET #LCAM #NSCLC * Klarenbeek, S. E. et al. (2023). Impact of time-to-treatment on survival for early-stage non-small cell lung cancer in The Netherlands-a nationwide observational cohort study. Translational lung cancer research, 12(10), 2015–2029. ** Goldman, J. W. et al. (2026). Event-free survival with adjuvant selpercatinib in stage IB–IIIA RET fusion-positive NSCLC: primary results of the phase 3 LIBRETTO-432 trial. ASCO 2026. 𝑇ℎ𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 𝑜𝑓 𝑡ℎ𝑖𝑠 𝑝𝑜𝑠𝑡 𝑖𝑠 𝑜𝑛𝑙𝑦 𝑎𝑝𝑝𝑙𝑖𝑐𝑎𝑏𝑙𝑒 𝑡𝑜: 𝐼𝑑𝑦𝑙𝑙𝑎™ 𝐸𝐺𝐹𝑅 𝑀𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝑇𝑒𝑠𝑡 (𝐴0270/6), 𝑤ℎ𝑖𝑐ℎ 𝑖𝑠 𝐶𝐸-𝑚𝑎𝑟𝑘𝑒𝑑 𝑖𝑛 𝐸𝑢𝑟𝑜𝑝𝑒 𝑖𝑛 𝑐𝑜𝑚𝑝𝑙𝑖𝑎𝑛𝑐𝑒 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝐸𝑈 𝐼𝑉𝐷 𝑅𝑒𝑔𝑢𝑙𝑎𝑡𝑖𝑜𝑛 2017/746 (𝐼𝑉𝐷𝑅), 𝑎𝑛𝑑 𝐼𝑑𝑦𝑙𝑙𝑎™ 𝐸𝐺𝐹𝑅 𝑀𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝑇𝑒𝑠𝑡 (𝐴0060/6) & 𝐼𝑑𝑦𝑙𝑙𝑎™ 𝐺𝑒𝑛𝑒𝐹𝑢𝑠𝑖𝑜𝑛 𝑃𝑎𝑛𝑒𝑙, 𝑤ℎ𝑖𝑐ℎ 𝑎𝑟𝑒 𝐶𝐸-𝑚𝑎𝑟𝑘𝑒𝑑 𝑖𝑛 𝐸𝑢𝑟𝑜𝑝𝑒 𝑖𝑛 𝑐𝑜𝑚𝑝𝑙𝑖𝑎𝑛𝑐𝑒 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝐸𝑈 𝐼𝑉𝐷 𝐷𝑖𝑟𝑒𝑐𝑡𝑖𝑣𝑒 98/79/𝐸𝐶. 𝐼𝑑𝑦𝑙𝑙𝑎™ 𝐸𝐺𝐹𝑅 𝑀𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝐴𝑠𝑠𝑎𝑦 𝑎𝑛𝑑 𝐼𝑑𝑦𝑙𝑙𝑎™ 𝐺𝑒𝑛𝑒𝐹𝑢𝑠𝑖𝑜𝑛 𝐴𝑠𝑠𝑎𝑦 𝑎𝑟𝑒 𝑓𝑜𝑟 𝑅𝑒𝑠𝑒𝑎𝑟𝑐ℎ 𝑈𝑠𝑒 𝑂𝑛𝑙𝑦 (𝑅𝑈𝑂), 𝑛𝑜𝑡 𝑓𝑜𝑟 𝑢𝑠𝑒 𝑖𝑛 𝑑𝑖𝑎𝑔𝑛𝑜𝑠𝑡𝑖𝑐 𝑝𝑟𝑜𝑐𝑒𝑑𝑢𝑟𝑒𝑠, 𝑖𝑛 𝑡ℎ𝑒 𝑈𝑆.

A inteligência artificial entra na rotina das UTIs Durante muitos anos, a tecnologia ajudou as UTIs a registrar informações, acompanhar indicadores e avaliar seus resultados. A Epimed IA representa um novo passo nessa evolução, incorporando inteligência artificial diretamente aos processos de trabalho. Desenvolvemos uma solução integrada com três agentes. O Data automatiza a coleta e o registro de informações clínicas. O Care apoia as visitas clínicas, a organização das tarefas e a passagem de plantão. O Advisor analisa indicadores e identifica oportunidades de melhoria do desempenho das UTIs. Estamos falando de uma nova capacidade de compreender informações, apoiar a execução dos processos e trabalhar continuamente ao lado das equipes assistenciais e de gestão. Como essa tecnologia pode influenciar indicadores acompanhados pelo programa UTIs Brasileiras, desenvolvido em parceria com a AMIB, decidimos oferecer a todas as instituições elegíveis a mesma oportunidade de conhecer e participar dessa nova etapa, evitando diferenças de oportunidade decorrentes do acesso seletivo à tecnologia. A primeira onda de implantação começa em janeiro de 2027. As instituições interessadas devem manifestar seu interesse até 23 de novembro. Nossa equipe está realizando reuniões individuais para apresentar a solução, avaliar sua aplicação em cada hospital e explicar as condições especiais de adesão, inclusive para leitos SUS. Quer participar da primeira onda da Epimed IA? Agende uma reunião com nossa equipe. O link está no primeiro comentário.

A inteligência artificial entra na rotina das UTIs Durante muitos anos, a tecnologia ajudou as UTIs a registrar informações, acompanhar indicadores e avaliar seus resultados. A Epimed IA representa um novo passo nessa evolução, incorporando inteligência artificial diretamente aos processos de trabalho. Desenvolvemos uma solução integrada com três agentes. O Data automatiza a coleta e o registro de informações clínicas. O Care apoia as visitas clínicas, a organização das tarefas e a passagem de plantão. O Advisor analisa indicadores e identifica oportunidades de melhoria do desempenho das UTIs. Estamos falando de uma nova capacidade de compreender informações, apoiar a execução dos processos e trabalhar continuamente ao lado das equipes assistenciais e de gestão. Como essa tecnologia pode influenciar indicadores acompanhados pelo programa UTIs Brasileiras, desenvolvido em parceria com a AMIB, decidimos oferecer a todas as instituições elegíveis a mesma oportunidade de conhecer e participar dessa nova etapa, evitando diferenças de oportunidade decorrentes do acesso seletivo à tecnologia. A primeira onda de implantação começa em janeiro de 2027. As instituições interessadas devem manifestar seu interesse até 23 de novembro. Nossa equipe está realizando reuniões individuais para apresentar a solução, avaliar sua aplicação em cada hospital e explicar as condições especiais de adesão, inclusive para leitos SUS. Quer participar da primeira onda da Epimed IA? Agende uma reunião com nossa equipe. O link está no primeiro comentário.

What does it take to automate sterility testing? More than automation technology. Developing SteriNow® required bringing together expertise in radiopharmacy, quality control, microbiology and sterility testing to design a solution that supports compliance, reduces contamination risks and improves operational efficiency. SteriNow® is an automated sterility testing workflow developed specifically for radiopharmaceutical production, that helped turn an industry challenge into a practical solution. But how did the project begin, and what made it possible? In this video, Charles Vriamont and Thomas Vergote, PhD, share the story behind SteriNow® and the collaboration with CUP Contract Labs that supported its development. Their experience highlights how complementary expertise, close collaboration and a shared commitment to innovation can help address some of radiopharmacy's most complex operational challenges. 👉 Want to go further? Watch our webinar for a deeper dive into automated sterility testing, implementation considerations and key lessons learned: lnkd.in/efvv99Ci 🔗 More information about SteriNow®: lnkd.in/e6AbB85H 📧 Contact us: info@trasis.com

Hoe vinden we meer vrijwilligers? Arwen Vangilbergen stelt na twee jaar vrijwilligerscoördinatie een andere vraag: hoe zorgen we dat mensen met interesse zich ook echt kunnen inzetten? Bij ACTIEF@thuis, een beweegprogramma voor kwetsbare thuiswonende 70-plussers, begeleidde ze beweegbuddy’s tussen 20 en 80 jaar. Ze reageerden allemaal op dezelfde vacature, maar hadden elk iets anders nodig. In haar gastbijdrage op onze blog beschrijft ze vijf profielen: 1. De gepensioneerde die actief wil blijven 2. De vrijwilliger voor wie het een opstap is naar iets anders 3. Wie zingeving zoekt in een moeilijke periode 4. De drukbezette vrijwilliger met vrijwilligerswerk als hobby 5. Wie een vriend of familielid wil helpen Per profiel lees je wat hen sterk maakt, waar ze mee worstelen en welke begeleiding werkt. Herkenbaar voor elke coördinator, ook buiten de zorg. Lees het artikel: lnkd.in/emRxHV-b Bedankt Arwen om je kennis te delen. Deel 2, met zes lessen over hoe je je werking organiseert, volgt later deze maand.

Greetings from Padua, home to one of the oldest universities in the world 🇮🇹 Today, we're here for the SYNTHEMA Symposium, and the discussions have already begun! After nearly four years of research, it's a special moment for our consortium to share what we've achieved with people interested in medicine, rare blood diseases and the possibilities of synthetic health data. We have a full day ahead, with sessions exploring everything from federated learning and synthetic patient cohorts to privacy, trust and the future of data-driven medicine. A heartfelt thank you to the Università degli Studi di Padova (UNIPD) / University of Padua, particularly Elisabetta Mezzalira and Raffaella Colombatti, for organising today's event and giving us such a warm welcome! Special thanks also go to Anna Rizzo for coordinating today's event, Federico Alvarez for leading the SYNTHEMA project throughout these years, and María del Mar Mañú Pereira for kindly providing the ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases) merchandise and adding a lovely touch to the occasion! More from Padua soon 🫶

Greetings from Padua, home to one of the oldest universities in the world 🇮🇹 Today, we're here for the SYNTHEMA Symposium, and the discussions have already begun! After nearly four years of research, it's a special moment for our consortium to share what we've achieved with people interested in medicine, rare blood diseases and the possibilities of synthetic health data. We have a full day ahead, with sessions exploring everything from federated learning and synthetic patient cohorts to privacy, trust and the future of data-driven medicine. A heartfelt thank you to the Università degli Studi di Padova (UNIPD) / University of Padua, particularly Elisabetta Mezzalira and Raffaella Colombatti, for organising today's event and giving us such a warm welcome! Special thanks also go to Anna Rizzo for coordinating today's event, Federico Alvarez for leading the SYNTHEMA project throughout these years, and María del Mar Mañú Pereira for kindly providing the ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases) merchandise and adding a lovely touch to the occasion! More from Padua soon 🫶

Room 12. The patient needs help. 🛏️ With LynX, the alarm button is always within reach - wherever your care team is. 📱 Mobile nurse call: staff carry the alarm function with them, wherever they go. 🎥 Camera integration: caregivers can check the situation remotely before heading to the room. The right alert, always within reach. A clearer view when it matters.

Athletes who waited at least 9 months after ACL reconstruction and passed strength and hop tests before returning had an 84% lower reinjury risk in the Delaware-Oslo cohort (Grindem et al., 2016). We wrote down the tests we use at each stage, from Return to Move (about 13 minutes, early rehab) to Return to Sport High Load with the full hop battery, strength testing and the ACL-RSI. Including the LSI cut-offs, and where LSI on its own misleads you. Free article: buff.ly/tyDN081 Return to Sport After ACL Reconstruction: tests and criteria hylyght.com/en/academy/e-learning/rehab/return-to-sport-after-acl-reconstruction-tests-and-criteria

🧠 Cette année encore, neuroClues exposera au congrès annuel de la Société Francophone des Mouvements Anormaux (SOFMA) ! Chaque année, le congrès de la SOFMA réunit les experts français des troubles du mouvement. Pour nous, c’est un rendez-vous à ne pas manquer. 📍 Paris, à l'ICM 📅 18 au 19 novembre C'est l'occasion : 👉 d'échanger avec les leaders d’opinion français en troubles du mouvement, dont les retours guident notre travail depuis le début. 👉 de présenter nos derniers développements : de nouvelles avancées pour rendre l’analyse des mouvements oculaires plus rapide, plus accessible et plus utile au quotidien des cliniciens. Les mouvements des yeux en disent long sur le cerveau. Vous serez aussi au congrès ? Venez nous rencontrer ou écrivez-nous dès maintenant pour fixer un moment d’échange. Vous y retrouverez toute l’équipe France : Antoine Pouppez, Armelle Roussac, Shirine Molaynejad et Joann Sidi Boulenouar ! À très vite ! #SOFMA #Neurologie #Parkinson #TroublesDuMouvement #EyeTracking #MedTech #Innovation #neuroClues

"Le Wheeleo®, c'est comme un membre de la famille. Il est là, il m'assiste tout le temps." Ce que décrit Valérie, c'est quelque chose de très simple : ne plus avoir à calculer chaque geste. Ne plus se demander si poser un verre, ouvrir une porte ou traverser le couloir est un risque. Parce que perdre son autonomie, elle le dit sans détour, c'est dur psychologiquement. Ce qui change tout, c'est d'avoir une aide qui ne prend pas de place, qui ne tombe pas, et qui libère une main. Et elle ne pense pas qu'à elle. En voyant ce que le Wheeleo® lui apporte au quotidien, elle pense immédiatement à tous ceux qui pourraient en avoir besoin. Vous ou un proche êtes concerné ? Parlez-en à votre kiné, à votre médecin ou testez-le dans un centre de revalidation : lnkd.in/eKhrK5PD

Zero receptionists voted “phone calls” as their biggest time sink. Yet 1 in 4 calls to clinics go unanswered. Over 4 weeks, we compared two data sets: 📊 What front desks told us 67% said check-in and paperwork eats their time. 33% said scheduling. 0% said phones. 📞 What clinic owners calculated (our free calculator) 1 in 4 calls goes unanswered, mostly between 8:30 and 11:00 AM. These two results are the same problem. When a patient is standing at the counter, the ringing phone loses. Nobody is being careless. One person can’t serve two queues at once. And the cost is real: 78% of first-time callers who hit a busy tone never call back. They book the next clinic. The fix isn’t asking staff to work harder. It’s separating the two streams: ✅ Staff stay 100% focused on patients in the clinic. ✅ Calls are answered on the 2nd ring. ✅ Reminders go out automatically by WhatsApp and SMS. Clinics using this approach get back 10 to 15 staff hours a week, and routine scheduling queries are handled without the front desk. Swipe through the full audit 👉 How many calls is your clinic missing? Our free 30-second calculator shows your number. No phone number change is needed, it’s GDPR-compliant and EU-hosted. Front desk teams and clinic owners: which side of this gap do you see? Tell me in the comments. #HealthcareInnovation #ClinicManagement #PatientExperience #HealthTech #PracticeManagement #DigitalHealth

Eén IT-partner die drie dingen tegelijk doet voor Belgische ziekenhuizen. Klinkt simpel, maar het is precies wat de zorgsector mist. Bij bITss combineren we al meer dan 19 jaar drie rollen die elders zelden onder één dak zitten. De komende weken nemen we jullie mee in elk van die rollen 👇 🔹 De vertaalslag tussen IT en ziekenhuizen 🔹 Kwaliteit en service aan een eerlijke prijs 🔹 Een werkplek waar mensen graag blijven Drie pijlers, drie posts. Samen vormen ze het verhaal van hoe wij ziekenhuizen en hun toeleveranciers ondersteunen met toekomstbestendige IT, zonder valse beloftes en zonder stress. Benieuwd? De eerste aflevering volgt snel. 🏥💡 #Healthcare #ITdienstverlening #Zorgsector #bITss

Last week we welcomed almost 100 participants (onsite and online) to our last MedTeG Medical Device Seminar of the year During two days Researchers, clinicians, entrepreneurs, industry professionals, and innovation experts explored one central question: how do we successfully translate promising medical technology research into solutions that reach patients and create healthcare impact? On day one, Prof Pascal Verdonck opened the seminar and positioned the impact of initiatives like these within the medtech valorisation ecosystem. Daan De Langhe provided valuable perspectives on incubating medical device innovations within a university environment, while Lieselot Burggraeve, Philippe Van Rompaey, and Chloë De Witte highlighted the realities of generating clinical evidence and conducting clinical studies in hospitals. Benedicte Nuyttens offered important guidance on navigating interactions with the FAGG and ethics committees, and Bjorn Delbeecke, LL.M, MBA shared his experience on the regulatory groundwork required before a first-in-human clinical study. On Day two the focus shifted towards protecting valorisation endavors and Securing commercialisation outcomes. Drawing lessons from Apple's innovation journey, Bjorn sparked discussion on overcoming the well-known "valley of death" between research and market adoption. Building on this case, Claire Verschelde further explored the strategic role of intellectual property in medical technology development. Stefanie Deronne provided valuable insights into reimbursement pathways, while David Aubert shared the entrepreneurial journey behind bringing phototherapy from the hospital environment into the home setting. Triggering lively discussions, challenging questions, and open exchanges on topics ranging from clinical evidence and regulatory strategy to IP, reimbursement, funding, and commercialisation. 👏 A sincere thank you to all speakers, participants, and partners for contributing to two inspiring days of learning, discussion, and collaboration. At MeDTeG, supporting the valorisation of medical technologies is at the heart of our mission and We look forward to continuing these conversations and supporting the next generation of medical technology innovations reaching impact. Pascal Verdonck Bjorn Delbeecke, LL.M, MBA Ewout Vansteenkiste Gilles Brackman UGent TechTransfer Office MedTeG beMedTech NoBoCap Project Biovia

Precision medicine promises therapies made for one patient. Each of them still has to be manufactured, from starting material that is different every time. Our CEO Jan Schrooten and Evan Claes will be at Science for health 2026 in Brussels on 10 November. This edition, Immunology reengineered, brings researchers, clinicians and industry together around the next generation of immune therapies, from CAR-T to engineered antibodies. Making sure a process is ready for manufacturing, that is where Antleron steps in. With scaled-down models, process monitoring and hybrid models, we help developers understand how their process responds to variable starting material, before the clinic depends on it. Evan is also presenting a poster during the poster sessions. More about his work later this week. Will you be at SQUARE as well? Come and say hello to Jan and Evan, or send them a message beforehand so we can plan a moment to talk. 📍 SQUARE Brussels 📅 10 November 2026 Antleron | Science for health | Biovia #SfH2026 #celltherapy #cellandgene #bioprocess

🧪 𝗦𝗽𝗲𝗲𝗱, 𝘀𝗶𝗺𝗽𝗹𝗶𝗰𝗶𝘁𝘆 𝗮𝗻𝗱 𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 𝗶𝗻 𝗖𝗹𝗼𝘀𝘁𝗿𝗶𝗱𝗶𝘂𝗺 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 The new PERFECTO Duo® method from Biokar Diagnostics combines the enumeration of Clostridium spp. and Clostridium perfringens on a single plate, delivering results in just 18 hours. Add a 15-minute confirmation step with CONFIRM' C. perfringens and you have a powerful solution to streamline your laboratory workflow. Because modern labs need more than accurate results. They need efficiency too. #FoodAndLifeScience #MicrobiologyTesting #FoodSafety #BiokarDiagnostics #LaboratoryInnovation #LedTechno #QualityAssurance

✨New Talent Alert✨ Amélie Van de Sande started her first day as Clinical Mobility Expert at CoMoveIT. With clinical knowledge and young enthusiasm, she’s reinforcing the team in supporting our partners and customers. Great to have you on board Amélie, a warm welcome from the entire CoMoveIT community!

✨New Talent Alert✨ Amélie Van de Sande started her first day as Clinical Mobility Expert at CoMoveIT. With clinical knowledge and young enthusiasm, she’s reinforcing the team in supporting our partners and customers. Great to have you on board Amélie, a warm welcome from the entire CoMoveIT community!

🌍 𝗟𝗲𝘁’𝘀 𝗺𝗲𝗲𝘁 𝗮𝘁 𝗠𝗘𝗗𝗜𝗖𝗔 𝟮𝟬𝟮𝟲! We’re excited to announce that we’ll be exhibiting at 𝗠𝗲𝗱𝗶𝗰𝗮 𝟮𝟬𝟮𝟲! Join us in Düsseldorf to discover out latest solutions & meet our team. 📅 𝟭𝟲 - 𝟭𝟵 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟲 📍 𝗛𝗮𝗹𝗹 𝟭𝟱, 𝗦𝘁𝗮𝗻𝗱 𝗗𝟭𝟵 We look forward to connecting with 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿𝘀, 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀, 𝗮𝗻𝗱 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 from around the world. 𝗦𝗲𝗲 𝘆𝗼𝘂 𝗶𝗻 𝗗ü𝘀𝘀𝗲𝗹𝗱𝗼𝗿𝗳! #medica2026 #healthcare #innovation

💬 TÉMOIGNAGES : Leur impression générale sur l'outil Pas de filtre, pas de script : juste des logopèdes qui partagent leur ressenti au quotidien. Et honnêtement, ça fait chaud au cœur. 💙 ⭐ Vous aussi, donnez votre avis : assistool.link/avis Pas encore membre ? Testez gratuitement pendant 14 jours sur assistool.be

Ehrliche Frage an alle Labore: Wie viele Stunden steckt ihr pro Woche in Routine-Schienen? A – unter 2 Stunden B – 2 bis 5 Stunden C – mehr als 5 Stunden Schreibt's in die Kommentare. Fachkräfte sind knapp, die Fallzahlen nicht – und genau bei Routinefällen hilft KI heute schon. In den nächsten Wochen zeige ich euch, wie. #zahntechnik #zahntechniker #dentallabor #digitaledentaltechnik #dentalcad #cadcam #aufbissschiene #3ddruck #dentaltechnik #kiimlabor #relu #reluautomate

What makes HASA OPTIX Belgium instruments stand out? Let's hear it from the experts. Check out Dr. Ossi Kaijanen speaking about his experience using our premium recyclable single-use instruments, and how they help him in the OR. For more information on our instrument range, be sure to reach out to our team! #Ophthalmology #CataractSurgery #Cataract

30% faster appeals processing and 75% fewer Medicare complaints — proof that smarter automation delivers real results. See how Sagility used AI to transform the appeals process for a Medicare Advantage plan: lnkd.in/eMQUQ-Vf  #MedicareAdvantage #AppealsandGrievances

MAGIS PHARMA VOUS ATTEND AU CONGRÈS SCIENTIFIQUE BON AIR ! Rendez-vous le 7 novembre 2026 à Genval pour rencontrer notre équipe au stand 18 ! Profitez d'une offre* exceptionnelle à l'occasion du congrès : 🎁 -40 % dès 150 € d'achat net
🎁 Un porte-spatules en inox offert (art. 4624482 – valeur de 42,39 €). Une occasion à ne pas manquer ! 👉 Découvrez notre webshop : loom.ly/U6Lz7EU *Offre valable du 02/11/2026 au 13/11/2026 inclus, dans la limite des stocks disponibles. Conditions : commande directe de minimum 150 € HTVA. Non applicable aux prix CMO, appels d'offres, prix contractuels, préparations, médicaments, dispositifs médicaux et produits/services non repris sur notre webshop. #magispharma #congrèsscientifique

MAGIS PHARMA VOUS ATTEND AU CONGRÈS SCIENTIFIQUE BON AIR ! Rendez-vous le 7 novembre 2026 à Genval pour rencontrer notre équipe au stand 18 ! Profitez d'une offre* exceptionnelle à l'occasion du congrès : 🎁 -40 % dès 150 € d'achat net
🎁 Un porte-spatules en inox offert (art. 4624482 – valeur de 42,39 €). Une occasion à ne pas manquer ! 👉 Découvrez notre webshop : loom.ly/U6Lz7EU *Offre valable du 02/11/2026 au 13/11/2026 inclus, dans la limite des stocks disponibles. Conditions : commande directe de minimum 150 € HTVA. Non applicable aux prix CMO, appels d'offres, prix contractuels, préparations, médicaments, dispositifs médicaux et produits/services non repris sur notre webshop. #magispharma #congrèsscientifique

La santé environnementale, on la cantonne souvent à la protection de la nature. C’est une vision bien trop étroite. Le 24 novembre à Namur, Pauline Modrie, Directrice Générale de Canopea, nous parlera des liens à construire entre santé et environnement : les enjeux et les défis que ce sujet pose concrètement, au cœur d’une journée dédiée au One Digital Health. Le sujet vous parle ? Alors rejoignez-nous sans plus tarder ! lnkd.in/et62pEvt

A milestone for #EnterpriseImaging in Italy! We are excited to announce that Istituti Fisioterapici Ospitalieri (IFO), in #Rome, #Italy, has renewed and upgraded its AGFA HealthCare Enterprise Imaging platform with integrated AI, advanced post-processing tools and AWS Cloud. Building on a collaboration that started with the first Enterprise Imaging implementation in 2020, the new agreement broadens the scope considerably, bringing together Enterprise Imaging for #Radiology and #NuclearMedicine, #RIS Elefante®, XERO® Universal Viewer, #VNA, advanced post-processing, clinical applications, AI, and monitoring and business intelligence tools. By bringing these tools together into one unified environment, the upgrade is making teams’ daily work simpler and systems more resilient. #Cloud-based business continuity and long-term archiving further strengthen IFO’s imaging infrastructure. The project also marks an important milestone: the first AGFA HealthCare Enterprise Imaging deployment on AWS Cloud in Italy. A big thank you to our customer IFO and our partners at Amazon Web Services (AWS) and Biesse Medica for their continued support and collaboration. A big thank you to AGFA Italy. Discover the perspectives of Giuseppe Navanteri, Chief Clinical Engineering and Technology Officer at IFO; Arianna Brugnoni, Sales and Marketing Manager at Biesse Medica; Dr Rowland Illing, Chief Medical Officer and Director at AWS; and Marco Arcelloni, Strategic Account Manager at AGFA HealthCare, on this collaboration and important milestone. Read the announcement: okt.to/IHV3oa Learn more about how AGFA HealthCare empowers Italian radiologists! Visit us at our SIRM booth B58 to meet our Italian team: Andrea Polticchia, Davide Fumagalli, Marco Arcelloni, Renato Iaccarino, Roberto Guarnieri, Marta Barberis, Elena Conte. Discover our booth educative session or request a hands-on demo: okt.to/ASJXqH #EmpowerImaging

📣 Policymakers are asking. Now SMEs will respond. The cabinets of Flemish innovation minister Matthias Diependaele and federal health minister Frank Vandenbroucke have asked for actionable recommendations directly from innovative #SMEs: ➡️ What pressures are you experiencing in Belgium’s health #innovation ecosystem, and which measures would make a real difference? At Science for Health 2026, the interactive closing panel brings this request directly to the ecosystem. 🔷 What should the government do in practical terms, both at regional and federal levels? 🔷 What does pharma’s position and future in #Belgium mean for smaller companies—their partnerships, clinical development, expertise and growth prospects? 🔷 How should Belgium approach competition and collaboration with China, and which conditions or support do innovators need? 📨 𝗦𝗳𝗛 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗲𝗿 𝗕𝗶𝗼𝘃𝗶𝗮 𝘄𝗶𝗹𝗹 𝗱𝗲𝗹𝗶𝘃𝗲𝗿 𝗰𝗼𝗻𝗰𝗿𝗲𝘁𝗲 𝗰𝗮𝘀𝗲𝘀 𝗮𝗻𝗱 𝗽𝗿𝗼𝗽𝗼𝘀𝗮𝗹𝘀 𝗱𝗶𝗿𝗲𝗰𝘁𝗹𝘆 𝘁𝗼 𝘁𝗵𝗲 𝗰𝗮𝗯𝗶𝗻𝗲𝘁𝘀 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝗶𝗻𝗽𝘂𝘁 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗮𝘂𝗱𝗶𝗲𝗻𝗰𝗲. Leading the discussion: 👉🏼 Pierre Raboisson | CEO & Founder, Coultreon Biopharma 👉🏼 Ann Van Gysel | CEO, Biovia 👉🏼 Tom Aelbrecht | COO & Head of Strategic Partnerships, Johnson & Johnson Campus Belgium ➡️ Moderated by Vanessa Vankerckhoven, CEO and Co-Founder of IDEVAX 📅 10 November 2026 | 📍 SQUARE Brussels | 🕓 16.30-17.15 Full #SfH2026 program ➡️ lnkd.in/eK7bZ2Fn 🎟️ Not yet registered? There are a few tickets left! lnkd.in/etEnsnWA #lifesciences #immunology #healthinnovation VLAIO - Flanders Innovation & Entrepreneurship | Johnson & Johnson Innovative Medicine | UCB

Could DASL-HiCaP influence how we manage non-metastatic prostate cancer with high-risk features? New data presented at ESMO 2026 provide an important opportunity to revisit treatment decisions in this setting. In this short video, a clinical case serves as the starting point to explore the DASL-HiCaP findings and consider their potential implications for clinical practice. 🎥 Watch the video for a concise overview of the data and reflections on how they may translate into everyday practice: lnkd.in/eBm3FGW5

What. A. Weekend. 🙌🏼💙 Last weekend, we brought OnTracx to Flanders Technology & Innovation Festival in Mechelen, and what a run it was! So many curious runners, screenings and insights 🏃🏼‍♂️ Over the weekend, runners stepped onto our treadmill to discover more about their own biomechanical running load. Each screening offered a glimpse into what makes every runner different: how much load their body experiences, how individual load and load tolerance can be, and why gradually building up towards a personal goal matters. Because there’s no one-size-fits-all approach to running. Understanding your own body is a valuable step towards making smarter training decisions and building towards your goals with confidence. 🎤The conversation continued on stage. On Saturday, Bonnaerens Senne joined Brent Luyckx and Sven Bulterijs, PhD for a panel discussion on “Can Technology Stop Injuries?”, moderated by Bavo Mortier. On Sunday, Kristof De Mey took part in “Health Tech, Data & Wearables”, alongside John Heymans and Brent Luyckx, with Evy Gruyaert as moderator. Two great conversations exploring the role of technology and data in the future of sport and health. We loved connecting with so many curious runners, sports professionals and fellow innovators throughout the weekend. A huge thank you to the FTI Sports NEXT team and everyone who stopped by our booth, stepped onto the treadmill or joined the conversation! From setbacks to comebacks. Together. 💙

Fresh from ESMO 2026 🔬 Catch up on some of the latest results in oncology presented at the congress. Plus, Jeremy Blanc shares his expert perspective on the VOLGA trial, evaluating perioperative durvalumab + enfortumab vedotin, with or without tremelimumab, in muscle-invasive bladder cancer. 👉 Read the latest Mirrors of Medicine newsletter below. This Week in Oncology: ESMO 2026 linkedin.com/pulse/week-oncology-esmo-2026-mirrors-of-medicine-li0he?trackingId=5gvG02gOy%2BxMFgAfA31Qbw%3D%3D

Fresh from ESMO 2026 🔬 Catch up on some of the latest results in oncology presented at the congress. Plus, Jeremy Blanc shares his expert perspective on the VOLGA trial, evaluating perioperative durvalumab + enfortumab vedotin, with or without tremelimumab, in muscle-invasive bladder cancer. 👉 Read the latest Mirrors of Medicine newsletter below.

Où sont les déficits de financement ? Et si on pouvait le savoir en temps réel ? Poursuivons notre tour d'horizon des solutions "Data Products" de Bluesquare. Aujourd'hui, coup de projecteur sur GAPS (Gap and Allocation Planning Suite) qui est l'outil automatisé sur mesure développé par Bluesquare pour permettre aux programmes de santé publique de : ✅ Détecter des incohérences dans les données financières ; ✅ Suivre précisément les déficits de financement ; ✅ Explorer différents scénarios d'allocation en temps réel ; ✅ Prendre des décisions budgétaires éclairées et basées sur des données fiables ; ✅ Négocier avec les donateurs à temps pour éviter le manque de financement GAPS centralise l'information et vous donne la visibilité nécessaire pour allouer les ressources là où elles auront le plus d'impact. 💬 Et vous ? Comment gérez-vous aujourd'hui le suivi des financements dans vos programmes ? Partagez votre expérience en commentaire, ou taguez un·e collègue confronté·e à ces défis budgétaires. 👉 Découvrez GAPS : lnkd.in/eq9dkKMb #GAPS #FinancementSanté #AllocationBudgétaire #DataForGood #SantéPublique

Before anyone designs a device, everyone in the room has to agree on what it's for. That was our starting point at the CapCell annual consortium meeting in Porto, hosted by i3S - Instituto de Investigação e Inovação em Saúde. CapCell is a four-year Horizon Europe research project, coordinated by Maastricht University. It brings together 13 partners from 8 countries: universities, forensic institutes, police forces and companies. The project tackles a hard problem in sexual-assault cases. Traces often hold cells from more than one person, and current DNA methods struggle to separate them, so evidence that could identify a perpetrator ends up unusable in court. CapCell combines microfluidics and single-cell genomics into a modular toolkit that isolates individual DNA profiles from those mixed traces. Voxdale's role is to help turn that research into devices forensic labs can use in their daily work, from prototype through testing and validation. The design and engineering work itself hasn't started yet. For now, we're laying the groundwork with partners by understanding where this new device will deliver the most value and the criteria that will determine its success in a forensic lab. Hard, but exciting work. Those priorities will guide every subsequent design decision. Here’s to keeping the collaboration going with field workers, researchers, and commercial partners, and making a significant difference in identifying sexual offenders.

Meer inzicht in je inkomsten als thuisverpleegkundige? Dat kan nu met CareConnect Nurse! Hoeveel heb ik verdiend deze maand? Hoe evolueren mijn inkomsten? En wat betekent dat voor mijn praktijk? Als zelfstandig thuisverpleegkundige wil je niet alleen je patiënten de beste zorg bieden, maar ook een duidelijk zicht hebben op je inkomsten. Daarom rollen we onze Inkomstensimulatie in CareConnect Nurse stap voor stap uit naar al onze klanten! Met deze slimme feature krijg je in enkele klikken een simulatie van je inkomsten. Selecteer eenvoudig een periode en een persoon en krijg meteen een overzicht. ✅ Snel en eenvoudig inzicht in je inkomsten ✅ Meer overzicht en controle over je praktijk ✅ Minder tijd kwijt aan administratie ➡️ Benieuwd hoe het werkt? Ontdek Inkomstensimulatie in onze video! Of vraag een demo aan via lnkd.in/e8c4aAPD #CareConnectNurse #Corilus #Thuisverpleging #Digitalisering #Zorginnovatie

🤔 "𝐖𝐡𝐚𝐭'𝐬 𝐭𝐡𝐞 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝐨𝐬𝐭𝐞𝐨𝐚𝐫𝐭𝐡𝐫𝐢𝐭𝐢𝐬 𝐚𝐧𝐝 𝐫𝐡𝐞𝐮𝐦𝐚𝐭𝐨𝐢𝐝 𝐚𝐫𝐭𝐡𝐫𝐢𝐭𝐢𝐬?" One of the first questions we received during the Q&A session at the Flanders Technology & Innovation Festival It's a great question because many people use the terms interchangeably, while they are actually very different conditions. 🔹 𝐎𝐬𝐭𝐞𝐨𝐚𝐫𝐭𝐡𝐫𝐢𝐭𝐢𝐬 is the most common form of arthritis. It is a degenerative joint disease in which the structures inside the joint gradually deteriorate over time. It often affects weight-bearing joints such as the knees and hips. 🔹 𝐑𝐡𝐞𝐮𝐦𝐚𝐭𝐨𝐢𝐝 𝐚𝐫𝐭𝐡𝐫𝐢𝐭𝐢𝐬 is an autoimmune disease. The body's immune system mistakenly attacks the joints, causing inflammation that can eventually damage joint tissue. Although both conditions can cause pain, stiffness and reduced mobility, their underlying causes are completely different, which means they require different treatment approaches. Questions like these remind us how important it is to continue raising awareness about musculoskeletal health and the science behind joint diseases. Thank you to everyone who joined the discussion at 𝐅𝐓𝐈 𝐅𝐞𝐬𝐭𝐢𝐯𝐚𝐥 and challenged us with thoughtful questions. We may turn a few more of them into educational posts over the coming weeks.

🚀𝐔𝐧 𝐜𝐥𝐢𝐜 𝐩𝐚𝐫 𝐣𝐨𝐮𝐫 𝐩𝐨𝐮𝐫 𝐬𝐨𝐮𝐭𝐞𝐧𝐢𝐫 𝐊𝐚𝐧𝐝𝐨 𝐂𝐚𝐫𝐞 - Digital Wallonia 🤩 Nous sommes en lice aux 𝐈𝐀 𝐀𝐰𝐚𝐫𝐝𝐬 𝟐𝟎𝟐𝟔 et nous avons besoin de vous 🙏 Kando Care, c’est renforcer la relation de soin entre les personnes âgées et les soignants, dans un secteur où l’on a de moins en moins de temps à consacrer au contact humain. Nous participons aux 𝐈𝐀 𝐀𝐰𝐚𝐫𝐝𝐬 𝟐𝟎𝟐𝟔 car nous sommes convaincus que l’intelligence artificielle est un levier pour redonner du temps à l’humain. Voter pour nous, c’est aussi contribuer à sortir enfin de l’ombre les maisons de repos, celles et ceux qui y travaillent et, surtout, les personnes âgées qui y vivent. Vous croyez en notre projet, alors n’hésitez plus ! 👉 Votez dès maintenant : lnkd.in/e3rwm4nW 🔄 Renouvelez votre vote tous les jours jusqu’au 15 novembre 📣 Parlez-en autour de vous 👇Une question sur Kando Care ? Posez-la en commentaire, nous serons ravis de vous répondre. #KandoCare #IAAwards2026 #IntelligenceArtificielle #HealthTech #SoinsAuxAînés

Join us on 4 December in Genk for the Regenerative Medicine Meuse-Rhine Conference (RMMR 2026), bringing together researchers, clinicians, companies and patients. Revatis is an active partner in the FIT Interreg project, contributing to several work packages and supplying muscle-derived stem cells (mdMSCs) to fellow consortium partners. I look forward to seeing you there and discussing progress and perspectives in regenerative medicine! 📍 Thor Central, Genk, Belgium — 4 December 2026, 10:00–17:00 👉 Programme and registration opened #Revatis #FITInterreg #RegenerativeMedicine

Immunotherapy in HR+ metastatic breast cancer: a PFS win, but no OS benefit. KEYNOTE-B49 final analysis 👇 lnkd.in/er5cYwqs Pembrolizumab Plus Chemotherapy for HR+/HER2− PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study KEYNOTE-B49 randomized 342 patients with PD-L1–positive (CPS ≥1) HR+/HER2− advanced #BreastCancer , progressing after endocrine therapy💊, to pembrolizumab or placebo plus chemotherapy. ➡️Pembrolizumab significantly improved PFS (HR 0.74; median 6.7 vs 6.0 months), with a numerically stronger signal at CPS ≥10 (HR 0.59). ➡️However, OS was not improved (HR 1.04; median 21.0 vs 22.2 months). Grade ≥3 treatment-related AEs occurred in 38% vs 33%. No new safety signals emerged. Hope Rugo Marleen Kok Anthony Gonçalves Delphine LOIRAT Giampaolo Bianchini David Cescon Yolanda Jerez Gilarranz Seock-Ah Im Kim Hirshfield Liyi Jia Konstantinos Tryfonidis Peter Schmid

Small recap about our impactful and colorful stand at Growth Across Borders.🧪 All along the day we welcomed and discussed with you, but in addition, we had a surprise for you… A game to win an audit with us! 🙌 Winners will be announced at the end week so… stay tuned! Bridge2Health (B2H)

How this year has flown by! Only two weeks to go until #IMSIS4! Our very own Alice Ly, will be in Kyoto to attend this meeting and happy to tell everyone about how we support and integrate all types of spatial biology techniques in Weave! #spatialbiology #sptiallipidomics #massspecimaging #histology #bioinformatics #teammassspec #neuroscience #AlzheimersDisease #Alzheimersresearch #ai4smox

Some of the hardest work in research communication begins when complex science has to make sense outside the project itself. As SYNTHEMA is in its final stretch, Sara Abu and Andrii Yaroshchuk, PhD from AUSTRALO reflect on what it has meant to communicate research on synthetic health data to audiences with very different levels of prior knowledge. The task was never simply to make topics such as federated learning, privacy-preserving technologies or synthetic data “easier”. It was to give people a clear way into the research without losing what makes the science meaningful. Someone encountering synthetic health data for the first time may need to understand why it matters for rare disease research. A clinician may be more interested in its potential use in practice, while a researcher may look for evidence, methods and limitations. The science is the same, but the way into it cannot be identical. For us, effective communication has meant deciding what people need to understand first, what can come later and which format is best suited to carry that message. That is how complex research becomes easier to follow without being reduced to a slogan. Dario Martinelli, AUSTRALO’s Head of Multimedia, explores the practical side of this in his training on making science visible, looking at how audience, hierarchy, format and visual clarity can help research become easier to understand, trust and use. Watch the training: lnkd.in/eDwXhc6C More about SYNTHEMA: synthema.eu

New DISCONTOOLS disease update: #ZoonoticPoxviruses Zoonotic poxviruses can affect animals and, in some cases, spread to humans, highlighting the close connection between animal and public health. They are also a good example of why a One Health approach perspective matters. Keeping disease information up to date is central to #DISCONTOOLS. With information covering over 50 infectious animal diseases, DISCONTOOLS identifies gaps in knowledge that can help accelerate the development of new disease control tools, including diagnostics, vaccines and pharmaceuticals. Through updates such as Zoonotic Poxviruses, DISCONTOOLS continues to provide current information on important animal diseases, including those with zoonotic relevance, supporting research priorities that benefit animal health and welfare, public health and a safe and secure food supply. 🙏 A big thank you to the expert group leaders who worked tirelessly to review and update the Zoonotic Poxviruses information: Jeremy Salt , Alessandra Scagliarini, Giliane Trindade, Jacqueline Weyer , #DavidHayman, Tanja Opriessnig, Martin Ludlow,Andreas Nitsche, Jonas Dutra Albarnaz 🔗 Explore the updated Zoonotic Poxviruses chapter on DISCONTOOLS here: lnkd.in/eX8FMePq #DISCONTOOLS #ZoonoticPoxviruses #OneHealth #Zoonoses #AnimalHealth #PublicHealth #DiseaseControl #Research

Next stop: Arena Clinical Trial Supply East Coast! Novitan is excited to be exhibiting at Arena Clinical Trial Supply East Coast on November 4–5 in King of Prussia, Pennsylvania. Thomas Ockier and Neil Armstrong look forward to meeting industry professionals, sharing insights, and exploring new opportunities for collaboration. 📍 Stop by Booth #50 - we'd love to connect! #Novitan #ClinicalTrialSupply #ClinicalTrials #CTS

Walk into any hospital ward and you will find clinicians juggling half a dozen digital systems, each guarding its own slice of a patient's story. An MRI sits in a radiology archive, blood results in a lab database, medication notes in an ageing record, lifestyle metrics in a phone that never pairs with anything else. A 2024 study by the European Hospital and Healthcare Federation put a number on that fragmentation: roughly EUR 2.5 million a year in manual reconciliation for a single 500-bed hospital. The Model Context Protocol is the most interesting response so far. Think of it as USB-C for healthcare data: one agreed port, so any compliant AI application can request the patient context it needs, in a secure, well-described format, without a bespoke integration per silo. The detail that matters is meaning, not just access. A model needs to understand that a potassium value of 5.1 means millimoles per litre, taken two hours after a diuretic, and not just a number in a spreadsheet. MCP defines that too. The upside is not a faster pilot. It is the end of the reconciliation tax, and AI built on context rather than fragments. Where in your organisation would a single context port change things first? #HealthAI #Interoperability #DigitalHealth #HealthTech #OpenInnovation

👁️ How does NVQ401 target the mechanisms that maintain the blood-retina barrier? NVQ401 is a highly potent bispecific antibody designed to restore the integrity of the blood-retina barrier by selectively activating Wnt/β-catenin signaling through Gpr124 and Lrp6. This approach builds on the well-established role of Wnt signaling in maintaining retinal vascular integrity. The pathway strengthens tight junctions, suppresses transcytosis (the transport of molecules through endothelial cells), and maintains barrier selectivity, all of which are essential for the structural and functional integrity of the blood-retina barrier. 🎧 Listen to Neuvasq’s CSO, Ralph Laufer, explains the scientific rationale behind NVQ401's approach to neurovascular barrier restoration.

Tarkastus alkaa. Hammaslääkäri käy hampaat läpi ja sanelee löydökset. “Kolmekuutosessa kolmospinnalla karies. Neljäseiskassa vanha amalgaami, reunat kunnossa. Taskut: neljä, kolme, viisi…” Samalla hän jutustelee potilaan kanssa. Kun tarkastus päättyy, kirjaus on jo valmiina. Karies on merkitty oikeaan hampaaseen ja oikealle pinnalle. Taskusyvyydet ovat parostatuksessa omilla paikoillaan, ja hammaskartta on päivittynyt. Potilaan rauhoittelu ja rento jutustelu eivät näy kirjauksessa. Hammaslääketieteellä on oma kielensä. Hampaat ja pinnat numeroidaan, ja löydökset sanellaan nopeasti. Suomeksi sama hammas ja sama löydös taipuvat kymmenissä muodoissa, varsinkin kun murteet lasketaan mukaan. Suomenkieliseen hammashoitoon rakennettu tekoälykirjuri ymmärtää, mitä hammaslääkäri tarkoittaa, ja tietää, mihin kohtaan statusta kukin löydös kirjataan. Hammaslääkäri tarkistaa ja hyväksyy kirjauksen. Kirjaukset siirtyvät yhdellä klikkauksella potilastietojärjestelmään. 💻 Nähdään hammaslääkäripäivillä loppuviikosta 3d18! Hammaslääkäripäivät 🦷 #suunterveys #hammaslääkäri #tekoäly #terveysteknologia #hammashoito

What if reducing stress during veterinary consultations could also improve the way we run our practices? 🐾 🐶 78.5% of dogs in one study showed fear on the examination table. 🐶 14% of dogs were reported to show severe or extreme fear during veterinary examinations. 🐶 22% of dog owners said they would visit their veterinarian more often if their dog experienced less stress. And it's not just about the dogs. In one survey, approximately 95% of companion animal veterinarians reported a work-related injury over a five-year period!! These numbers highlight why reducing stress in veterinary practice matters. For our patients, their owners and the veterinary teams caring for them. Last month, I had the pleasure of giving a talk during the vet academy day at Just Russel to fellow veterinarians about stress-free veterinary consultations for dogs. We explored the science behind fear and stress during veterinary visits, but more importantly, how we can translate that knowledge into practical changes. One of the most interesting parts of our discussion was how to integrate these approaches into a busy veterinary practice: How can we improve animal welfare and team safety while maintaining an efficient schedule and a financially sustainable practice? Thank you, Just Russel, for the invitation and the engaging discussions!

An EV process that works once is not the same as an EV process that works every time. Getting from the first to the second is where most of the work sits between discovery and a clinical batch. We are in Berlin this week for Exosomes Europe 2026. Our co-founder and CEO Jan Schrooten opens day two on Thursday 5 November at 09:05 with "Smart EV Biomanufacturing: Balancing Yield, Purity & Scale from Lab to Clinic", the first talk of the downstream purity and quality control track. Three things we want to discuss while we are there:  • Scaled-down models, so the EV process data you generate in the lab still holds at GMP scale  • A digital toolbox of hybrid models and other digital solutions, made available through our platform Antleron Nexus  • Closed automated production, with fewer open steps and more consistent batches If you are at Hotel Palace on 4 or 5 November, send us a message and we will find a moment. 📍 Hotel Palace, Berlin 📅 5 November 2026 Informa Connect Life Sciences #ExosomesEurope #extracellularvesicles #bioprocess #biomanufacturing

🇵🇹 1 WEEK TO GO! Lisbon is about to become the global capital of technology! ⚡ Next Monday, the GreenLane AI team will be at Web Summit 2026, bringing our latest AI innovations to the global technology stage. From transforming healthcare operations with AI-powered automation to building intelligent patient engagement solutions, we're excited to connect with the people shaping the future of technology. Whether you're a founder building the next big innovation, an investor exploring emerging AI opportunities, a healthcare provider embracing digital transformation, or a business looking to expand internationally — let's connect! 🇧🇪 Proud to represent Belgium and the Walloon innovation ecosystem on the global technology stage. We are delighted to bring our Belgian innovation and international ambitions to Lisbon. 📍 FIND GREENLANE AI AT WEB SUMMIT 2026 🗓️ Dates: November 9–12, 2026 🏢 Location: Pavilion 3 🎯 Booth: PS10-08 What can you discover at Booth PS10-08? 🔹 Live, hands-on demonstrations of GreenLane AI 🔹 Explore our AI-powered healthcare automation and patient engagement solutions 🔹 Meet our founding team and discuss our 2027 international growth roadmap 🔹 Explore partnership, investment and collaboration opportunities 🔹 Exclusive GreenLane AI merchandise (while supplies last!) When we're not at the booth, you'll find us attending Startup Masterclasses, exploring emerging technologies and connecting with the global startup ecosystem. ☕ LET'S MEET IN LISBON! 👇 Attending Web Summit? 1. Comment "LISBON" below so we can connect. 2. Send us a direct message or connect through the official Web Summit app. 3. Let's schedule a 15-minute coffee chat and explore how we can collaborate. See you at Pavilion 3, Booth PS10-08! 🇧🇪 Building from Belgium. Innovating for global healthcare. Connecting with the world. #WebSummit2026 #GreenLaneAI #AWEX #Wallonia #Belgium #HealthcareAI #HealthTech #AgenticAI #DigitalHealth #ArtificialIntelligence #BelgianInnovation #GlobalInnovation

🌍 Meet D-Tek s.a. at MEDICA 2026 in Düsseldorf! We are pleased to announce that D-tek will be attending MEDICA 2026, one of the world's leading medical trade fairs! We look forward to connecting with our partners, distributors, and industry professionals to discuss our latest innovations in autoimmune diagnostics and explore new opportunities for collaboration. 📅 November 16–19, 2026 | Düsseldorf, Germany 🤝 Want to meet us at MEDICA? Contact us to schedule a meeting with our team! #MEDICA2026 #Dtek #AutoimmuneDiagnostics #IVD #Innovation #MedicalDiagnostics #CEIVDR #multiplex

Innovation is not in short supply in clinical research. The challenge is connecting technology, data, processes, and people in a way that creates measurable and sustainable change. Today at the Fortrea Innovation & Technology Summit EU in Basel, Dominique Demolle, CEO of Cognivia, joins leaders from Fortrea and Veeva Systems to explore how our industry can move beyond individual innovations and work collectively toward transforming clinical development at scale. Looking forward to discussing what it will take to turn promising technologies into real-world impact for sponsors, sites, and patients.

Last Thursday our Managing Director, Jan Van Wijnendaele, joined the panel at the #ZigZagHR Forum. His key takeaway: employers already invest heavily in support, yet employees with a real care need often don’t know where to start. HR doesn’t have to become a healthcare provider, but it can be the link that makes professional support easier to reach. Read Jan’s full reflection in his post below 👇 #doktr #healthcare #wellbeing #hr

🌸 Syndrome prémenstruel : et si l’approche intégrative permettait de porter un regard plus global sur le cycle féminin ? Au-delà des fluctuations hormonales, de nombreux facteurs méritent d’être explorés : statut micronutritionnel, alimentation, neurotransmission, sommeil, stress et mode de vie. 🔬 Comment articuler ces différents paramètres dans une stratégie nutritionnelle et micronutritionnelle cohérente ? Pour approfondir cette question, le laboratoire LEPIVITS SA vous invite à un webinaire dédié aux professionnels de santé, animé par Pierre Van Vlodorp, nutrithérapeute, naturopathe, conférencier et formateur, fort de plus de 15 ans d’expérience. Au programme : 🔹 Comprendre le SPM à travers une lecture multifactorielle et intégrative. 🔹 Explorer la place de l’alimentation, de la micronutrition et de la phytothérapie dans l’accompagnement du cycle féminin. 🔹 Faire le point sur les données scientifiques relatives à certains actifs végétaux, notamment le safran, le gattilier et l’alchémille. 🔹 Découvrir l’approche micronutritionnelle développée par notre laboratoire au sein de la LEPIVITS® à destination des professionnels de santé. 📅 Jeudi 19 novembre 2026 🕧 12h30 (heure de Bruxelles/Paris) 💻 En ligne | Durée : environ 1 heure 👉 Vous êtes praticiens de santé ? Réservez votre place dès maintenant : lnkd.in/eDBfvuvX Un rendez-vous pour enrichir vos connaissances et nourrir votre réflexion autour d'un accompagnement individualisé de la santé féminine. #lepivits #webinaire #micronutrition #santefeminine #praticiens

🌸 Syndrome prémenstruel : et si l’approche intégrative permettait de porter un regard plus global sur le cycle féminin ? Au-delà des fluctuations hormonales, de nombreux facteurs méritent d’être explorés : statut micronutritionnel, alimentation, neurotransmission, sommeil, stress et mode de vie. 🔬 Comment articuler ces différents paramètres dans une stratégie nutritionnelle et micronutritionnelle cohérente ? Pour approfondir cette question, le laboratoire LEPIVITS SA vous invite à un webinaire dédié aux professionnels de santé, animé par Pierre Van Vlodorp, nutrithérapeute, naturopathe, conférencier et formateur, fort de plus de 15 ans d’expérience. Au programme : 🔹 Comprendre le SPM à travers une lecture multifactorielle et intégrative. 🔹 Explorer la place de l’alimentation, de la micronutrition et de la phytothérapie dans l’accompagnement du cycle féminin. 🔹 Faire le point sur les données scientifiques relatives à certains actifs végétaux, notamment le safran, le gattilier et l’alchémille. 🔹 Découvrir l’approche micronutritionnelle développée par notre laboratoire au sein de la LEPIVITS® à destination des professionnels de santé. 📅 Jeudi 19 novembre 2026 🕧 12h30 (heure de Bruxelles/Paris) 💻 En ligne | Durée : environ 1 heure 👉 Vous êtes praticiens de santé ? Réservez votre place dès maintenant : lnkd.in/eDBfvuvX Un rendez-vous pour enrichir vos connaissances et nourrir votre réflexion autour d'un accompagnement individualisé de la santé féminine. #lepivits #webinaire #micronutrition #santefeminine #praticiens

With the European Health Data Space now moving to implementation, questions around the governance of health data are becoming increasingly concrete. At the same time, the growing use of AI in healthcare and emerging debates around neurodata raise broader questions around privacy, autonomy, access and the governance of highly sensitive data. At CPDP 2026, sessions explored these developments through discussions on the European Health Data Space, medical AI, mental privacy, neural data, and increasingly data-driven healthcare systems. Below, you can find recordings of the sessions covering these topics. lnkd.in/ezyveDR7  #CPDP2026 #CompetingVisionsSharedFutures

Derrière les chiffres de Simplycure, il y a un sujet dont on parle peu en public : la relation entre associés, et avec l’équipe. Avec Victor Boels, on a monté la boîte à deux. On n’a pas le même caractère, pas toujours la même façon de voir les choses, et à quinze personnes, chaque désaccord entre fondateurs se ressent dans toute l’équipe. Ça ne se règle pas tout seul. C’est un apprentissage qui prend du temps. C’est pour ça qu’on se fait accompagner depuis quelques années par Filip GRISAR, de Quantum Change. On se pose régulièrement avec lui, à deux ou avec l’équipe. On met sur la table ce qui frotte, et on en sort avec un cadre écrit plutôt qu’avec des non-dits. Ce que ce travail nous apporte, ce n’est pas d’être toujours d’accord. C’est d’avoir un langage commun pour se dire les choses : ce qu’on attend l’un de l’autre, comment on décide, comment on se fait du feedback sans que ça devienne personnel. Ce cadre, on l’a d’abord construit entre nous deux, puis on l’a ouvert à toute l’équipe. Nos valeurs et nos operating principles sont nés de ces séances. Aujourd’hui, ils permettent à chacun de décider sans attendre et d’avancer ensemble, même quand on n’est pas d’accord. Une erreur qu’on a commise au départ, c’est d’avoir passé beaucoup de temps sur le produit et les ventes, et pas assez sur la relation qui tient tout le reste. Et ce n’est jamais fini. Chaque étape remet le cadre en question : nouveaux recrutements, nouveau marché, une période plus dure. C’est un travail continu, qui demande autant d’attention que le reste. Merci Filip pour l’accompagnement, et merci Victor pour ta confiance depuis quasiment 10 ans !

Peptide. Impurities. Excipients. One HILIC run ✔ Earlier this year we said never to underestimate the small ones. This week in Amsterdam, we’ll show you why. In our previous peptide therapeutics recap, we showed how lipidation, Aib substitutions and optimized spacers turn a hormone that survives only minutes in the body into once-a-week medicines like semaglutide. However, every design choice adds critical quality attributes (CQAs) to your list. The GLP-1 drug product is more than its peptide. Across Ozempic, Byetta and Xultophy, you’ll also find tonicity agents, co-solvents, buffer salts and preservatives. RPLC remains the gold standard for peptide purity, but RPLC-UV was never built to see a polyol or a phosphate ion. At TIDES Europe (November 3-5, RAI Amsterdam), our colleagues Piotr and Thomas will be presenting some of our latest work, in collaboration with our friends at Agilent Technologies. One HILIC method. Three detectors (UV-MS-ELSD). Three marketed drug products. And there’s a twist involving stainless steel, but we would rather tell you that one in person 🤓 📍 Find us at TIDES: Oligonucleotides and Peptide Therapeutics and bring your toughest peptide characterization question! Not in Amsterdam? Read our recap on peptide design, CQAs and lifecycle-ready analytics here 👉 lnkd.in/eBpMEaFA #TIDESEurope #peptides #GLP1 #HILIC #CMC #analytics #RICbiologics

We are delighted that Sencilia has raised approximately €2 million, led by NV NOM, together with our existing investors Future Tech Ventures, imec.istart The Netherlands, RUG Ventures and Triade, all of whom have invested in us again, alongside private investors with backgrounds in the infusion industry. The financing is complemented by a Eureka Eurostars subsidy from the Netherlands Enterprise Agency (RVO) and an innovation loan from Rabobank. With this funding, we will advance Rely-V® toward production, generate further clinical evidence, and expand our collaborations with infusion pump and IV set manufacturers. A special thank you to the people who worked so hard behind the scenes to make this round happen (tagged in the comments below), and to our investors, partners and team. We are excited to work together toward safer infusion therapy! Note: Rely-V® is an investigational device and is not available for sale.

We're #hiring a new Sr. Clinical Project Manager - Cardio / Metabolic in European Union. Apply today or share this post with your network.

Your monthly update on novel drug submission activity.

Every session at GDHS 2026 could reshape your thinking, challenge your assumptions, and influence your next big decision. If you have the power to shape the future of your medical practice or organisation, regardless of its size, this Summit will help you lead that future rather than react to it.

Extremely happy to announce ANIMA Research is the final GLOBAL TOP ENROLLER in a WW early stage study in Vitiligo as previously in other WW clinical trials, prooving the key value proposition of ANIMA Research.

La Commission européenne vient de publier son bilan annuel sur la décennie numérique en Europe : la Belgique y est saluée pour la qualité de ses infrastructures de données de santé, mais le même rapport pointe un déploiement de l’intelligence artificielle dans les soins encore limité et inégal selon les établissements. On retrouve cette tension dans notre bibliothèque de ressources, avec une intervention du Pr Philippe Coucke qui plaidait pour une médecine appuyée sur une exploitation intelligente des données réelles des patients. Une réflexion qui n’a rien perdu de sa pertinence : lnkd.in/eh_aSh6H Et dans votre établissement, la donnée se traduit-elle déjà en décisions cliniques concrètes ?

Heading to Boston to meet one-to-one or at dinner multiple Top 20 Pharma Partners as accepted. ANIMA Research ANeuroTech

Heading to Boston to meet one-to-one or at dinner multiple Top 20 Pharma Partners as accepted. ANIMA Research ANeuroTech

𝗗𝗿𝗮𝗽𝗶𝗻𝗴 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗶𝗻 𝘂𝗻𝗱𝗲𝗿 𝗮 𝗺𝗶𝗻𝘂𝘁𝗲 𝗶𝘀𝗻'𝘁 𝘄𝗶𝘁𝗰𝗵𝗰𝗿𝗮𝗳𝘁. 𝗜𝘁'𝘀 𝘁𝗵𝗲 𝗠𝗲𝗱𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻 𝗘𝘀𝘆𝗦𝘂𝗶𝘁™ 𝗥𝗮𝗻𝗴𝗲. Forget the tricks. The EsySuit™ Range makes patient preparation fast and consistent, with draping completed in under one minute. Less draping. More surgery. No magic required. Discover the EsySuit™ Range at medenvision.com Happy Halloween! 🎃 #EsySuit #Orthopaedics #SurgicalEfficiency #OperatingRoom #MedEnvision

Is social media harming our minds, or is the debate bigger than the headlines🧠 On 20th November 2026, the Global Digital Health Summit, Expo & Innovation Awards brings together psychiatrists, researchers and founders at Bharat Mandapam for a Spotlight Session on Mental Health & Digital Age: Challenges, Opportunities & the Startups. We will look at the questions people are asking right now: evidence versus propaganda in the social media ban debate, loneliness in a hyperconnected world, cognitive decline in the age of AI, and neurodiversity in India. We will also hear how startups are building real solutions, with a showcase of mental health innovators. Keynote by Dr. Rajinder K Dhamija, Director, IHBAS. Hosted in partnership with Health Parliament, Institute Of Human Behaviour And Allied Sciences (IHBAS) 📅 20th November 2026 | 10.30 AM to 1.00 PM 📍 Bharat Mandapam, New Delhi 🔗 Register at www.globalsummit.health (add the Mental Health Spotlight Session to your Delegate Pass) #MentalHealth #DigitalWellbeing #SocialMediaBan #Loneliness #Neurodiversity #AIandMentalHealth #CognitiveHealth #GenZ #MentalHealthStartups #DigitalHealth #GDHS2026 #HealthTech #BharatMandapam Ruma Chaturvedi Dr. Deepak Raheja Dr Pallavi Rajhans Sriram Ganapathy Ritika Arora Dr. Rajendra Pratap Gupta, PhD Mevish P. Vaishnav

Un enfant de 4 ans présente de la fièvre. Quel signe d’alarme nécessite une évaluation médicale immédiate ? 👉 Découvrez le cas clinique dans ce carrousel, choisissez votre réponse et faites défiler les pages pour découvrir l’explication. En consultation, vous souhaitez pouvoir accéder rapidement aux recommandations. Avec l’Assistant aux connaissances médicales, posez votre question clinique directement dans CareConnect GP et obtenez une réponse étayée, accompagnée de références aux sources. Vous avez ainsi les recommandations pertinentes à portée de main pour éclairer votre jugement clinique. Votre prochaine question ? Posez-la dans CareConnect GP. 👉 En savoir plus : hubs.la/Q04CTxHH0 #CareConnectGP #MédecineGénérale #evidencebasedsearch #Corilus

Een kind van 4 jaar met koorts. Welk alarmsymptoom vraagt om onmiddellijke medische beoordeling? 👉 Neem de casus in deze carrousel door, kies je antwoord en swipe naar de toelichting. Ook tijdens je consultatie wil je een richtlijn snel kunnen raadplegen. Met de Medische Kennis Assistent stel je je klinische vraag rechtstreeks in CareConnect GP en krijg je een onderbouwd antwoord met bronvermelding. Zo ondersteun je je klinische afweging met de relevante richtlijn bij de hand. Je volgende vraag? Stel ze rechtstreeks in CareConnect GP. 👉 Meer info: hubs.la/Q04CTw4n0 #CareConnectGP #Huisartsgeneeskunde #evidencebasedsearch #Corilus

Un pompier pour ouvrir un symposium sur le One Digital Health, ce n’est pas un hasard. Le Capitaine Vincent Bouffa, de la Zone de secours Liège 2, fera une mise en contexte pour démarrer la journée, le 24 novembre à Namur. Parce que quand les fagnes brûlent, c’est la santé humaine, animale et environnementale qui en subit les conséquences, souvent en même temps. Un choix qui en dit beaucoup sur ce que cette journée veut explorer : la santé ne commence pas à la porte de l’hôpital, et le terrain le sait mieux que quiconque. Vous pouvez vous inscrire dès maintenant : lnkd.in/et62pEvt

How can advanced materials help shape the next generation of medical devices? From implantable devices to surgical instruments, material selection plays a critical role in meeting increasingly complex healthcare requirements. At Syensqo, we combine more than 60 years of high-performance polymer innovation with deep application expertise to help medical device manufacturers overcome design challenges and bring new solutions to life. Our medical-grade polymers support a wide range of applications, including: - Implantable devices, combining long-term biocompatibility, mechanical strength, lightweight, dimensional stability and MRI compatibility - Limited-use and reusable surgical instruments, supporting metal replacement through lightweight, strength, toughness, chemical resistance and application-specific sterilization compatibility Join us at #COMPAMED2026 at Booth 8AL14 to explore how our materials and expertise can support your next healthcare innovation. Discover our solutions for medical devices: bit.ly/4stWKPr #Syensqo #AdvancingHumanity #COMPAMED #Healthcare #MedicalDevices

Reclaim your clinical attention at #RSNA2026. Clinical attention is one of healthcare's most valuable resources. How can we help radiologists reclaim more of it? At RSNA 2026, Nathalie McCaughley, President of AGFA HealthCare, invites you to discover what's possible when viewing, intelligent workflow orchestration, reporting, and embedded AI come together in one unified Enterprise Imaging platform. At AGFA HealthCare, we believe technology should empower clinicians to work more efficiently, stay in flow, and focus more attention on what matters most: patient care. One platform. One clinical experience. 📍 Visit us at Booth #2119 to experience it firsthand. 👉 Book your personalized demo: okt.to/9NCLqK #RSNA2026 #EnterpriseImaging #Radiology #HealthcareIT #AGFAHealthCare

Skin conditions don’t start on skin; they start in the gut. We reviewed nine skin conditions, from acne to psoriasis to alopecia areata. For many of them, gut microbiome dysbiosis is well established. Yesterday, I talked about what that tells us about the connection between the gut and the skin. I spoke at the Scientific Symposium of the Royal Belgian Society of Cosmetology in my hometown, Gent. My talk "The Gut/Skin axis and the role in skin diseases" builds on our highly-citeda review paper we published a couple of years ago, where we looked at nine dermatological conditions: acne vulgaris, atopic dermatitis, psoriasis, hidradenitis suppurativa, rosacea, alopecia areata and others. In every one of them, we documented an altered skin microbiome. For many skin conditions, gut microbiome dysbiosis is well established. Hidradenitis suppurativa comes with a significantly increased risk of Crohn's disease and ulcerative colitis. Rosacea is associated with small intestinal bacterial overgrowth (SIBO), and in clinical studies, eliminating SIBO produced a significant reduction in skin lesions. For alopecia areata, a case report described hair re-growth after fecal microbiota transplant in two patients. For other conditions, the gut microbiome picture is still unclear, unreported or contested. I find that gap as interesting as the confirmed associations, because it shows where the gut-skin connection is still an open question. It was wonderful to connect with everyone! Review: Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions. Microorganisms 2021, 9, 353. lnkd.in/ewFyKida  Thanks to Britta De Pessemier, Lynda Grine, Melanie Debaere, Aglaya Maes and Bernhard Paetzold for making the review possible.

Na het panelgesprek op het #ZigZagHR Forum bleef één gedachte echt hangen: De volgende stap in wellbeing is niet per se méér doen, maar mensen beter helpen vinden wat ze nodig hebben. Werkgevers investeren sterk in ondersteuning. Toch weten medewerkers met een concrete zorgvraag vaak niet waar ze moeten beginnen. Huisartsentekorten, wachttijden en een versnipperd zorglandschap maken de weg naar passende zorg bovendien steeds complexer. Daarom moeten we evolueren van een wellbeingaanbod naar verbonden toegang tot welzijn én zorg. HR hoeft geen zorgverlener te worden. HR kan wel een belangrijke schakel zijn door medewerkers vanuit hun vertrouwde werkomgeving eenvoudiger toegang te geven tot professionele ondersteuning: • een zorgvraag beter inschatten; • sneller de juiste mentale of fysieke ondersteuning vinden; • en bij uitval begeleid terugkeren naar het werk. Daar ondersteunen we organisaties vandaag al bij met 💚 Doktr: door mensen eenvoudigere toegang te geven tot fysieke en mentale zorg, ingebed in ons breder ecosysteem van HR-en gezondheidspartners. Tegelijk evolueren we verder van videoconsultatie naar zorgnavigatie, beter geïntegreerd in de omgevingen waarin mensen leven en werken. Want wellbeing krijgt pas echt impact wanneer ondersteuning niet alleen wordt aangeboden, maar ook vindbaar, bereikbaar en verbonden is. Dank aan #ZigZagHR, Lesley Arens en Sven Hubin voor de organisatie, en aan Olivier Kleynjans, Cedric De Vleeschauwer en moderator Dagmar Van Gucht voor het inspirerende panelgesprek. #Doktr #HR #Wellbeing #CareNavigation #EmployeeHealth #HybridCare

💡 Et si l’intelligence artificielle nous aidait à préserver notre autonomie et notre qualité de vie ? C’est l’ambition d’un projet innovant mené en collaboration par le CHU UCL Namur et l'Université de Namur, actuellement en lice pour les « Awards de l’IA » de Digital Wallonia, dans la catégorie IA & Santé 🏆 ! 🎯 L’objectif ? Détecter la perte de masse musculaire qui peut accompagner certaines maladies, notamment le cancer, et certains traitements comme la chimiothérapie ou la radiothérapie. Car préserver les muscles, c’est aussi préserver la mobilité, l’autonomie, la qualité de vie des patients et leur capacité à mieux supporter les traitements 💪 . Porté par François-Xavier Hanin, médecin spécialiste en médecine nucléaire au CHU UCL Namur, et Médéa Locquet, professeure à l’UNamur, ce projet mise sur le deep learning pour analyser les CT scans réalisés dans le cadre du suivi des patients atteints de cancer et mieux identifier les patients les plus vulnérables aux traitements. 🤝 Cette belle collaboration entre l’hôpital et l’université a permis à Camille Ditroia, étudiante en Sciences biomédicales à l’UNamur, de contribuer activement au développement de cet outil d’intelligence artificielle dans le cadre de son mémoire de master, sous la co-promotion de François-Xavier Hanin et Médéa Locquet. 📢 Aujourd’hui, leur projet est en finale… et ils ont besoin de VOUS !!! 🗳️ Votez pour le projet du CHU UCL Namur aux IA Awards 2026 - catégorie IA & Santé : lnkd.in/ejxPZ86s 🙌 Ensemble, soutenons l’innovation et la recherche collaborative au service des patients ! #IAAwards2026 #IntelligenceArtificielle #Santé #Innovation #UNamur #CHUUCLNamur #DigitalWallonia

💡 Et si l’intelligence artificielle nous aidait à préserver notre autonomie et notre qualité de vie ? C’est l’ambition d’un projet innovant mené en collaboration par le CHU UCL Namur et l'Université de Namur, actuellement en lice pour les « Awards de l’IA » de Digital Wallonia, dans la catégorie IA & Santé 🏆 ! 🎯 L’objectif ? Détecter la perte de masse musculaire qui peut accompagner certaines maladies, notamment le cancer, et certains traitements comme la chimiothérapie ou la radiothérapie. Car préserver les muscles, c’est aussi préserver la mobilité, l’autonomie, la qualité de vie des patients et leur capacité à mieux supporter les traitements 💪 . Porté par François-Xavier Hanin, médecin spécialiste en médecine nucléaire au CHU UCL Namur, et Médéa Locquet, professeure à l’UNamur, ce projet mise sur le deep learning pour analyser les CT scans réalisés dans le cadre du suivi des patients atteints de cancer et mieux identifier les patients les plus vulnérables aux traitements. 🤝 Cette belle collaboration entre l’hôpital et l’université a permis à Camille Ditroia, étudiante en Sciences biomédicales à l’UNamur, de contribuer activement au développement de cet outil d’intelligence artificielle dans le cadre de son mémoire de master, sous la co-promotion de François-Xavier Hanin et Médéa Locquet. 📢 Aujourd’hui, leur projet est en finale… et ils ont besoin de VOUS !!! 🗳️ Votez pour le projet du CHU UCL Namur aux IA Awards 2026 - catégorie IA & Santé : lnkd.in/ejxPZ86s 🙌 Ensemble, soutenons l’innovation et la recherche collaborative au service des patients ! #IAAwards2026 #IntelligenceArtificielle #Santé #Innovation #UNamur #CHUUCLNamur #DigitalWallonia

How could the DASL-HiCaP results influence treatment decisions for patients with high-risk prostate cancer? In this short clip, Dr. Tamim Niazi discusses his treatment approach and where darolutamide could fit into practice. ▶️ Watch the full video: lnkd.in/eBm3FGW5 #ProstateCancer #DASLHiCaP #GUOncology #RadiationOncology

OpenHEXA au Niger : un pas de plus vers la souveraineté du pays sur ses données de santé Comment un ministère de la Santé prend-il pleinement en main sa propre plateforme de données ? Au #Niger, du 21 au 25 octobre, une vingtaine de cadres du Ministère de la Santé et de l’Hygiène Publique se sont réunis à Dosso, à l’initiative de la Direction de la e-Santé, pour approfondir leur maîtrise de #OpenHEXA : espaces de travail, pipelines, gestion des accès, articulation avec #DHIS2 et les outils de visualisation. Depuis 2021, OpenHEXA alimente des produits de données clés du Ministère : l’Entrepôt national du paludisme (EnDoP) et la SNT Toolbox avec le PNLP, la carte sanitaire avec la DS, les tableaux de bord des campagnes digitalisées de la DI et le bulletin mensuel automatisé de la DSRE. En 5 jours, le score moyen au test de connaissances est passé de 67,2 % à 87,8 %. En fin d’atelier, 100 % des répondants dépassaient le seuil de 70 %, contre 55,6 % au départ. La plateforme est déjà hébergée dans le centre de données du Ministère. Prochaine étape : un atelier pratique pour y migrer les espaces de travail et leurs données et rendre la plateforme pleinement opérationnelle. Merci à tous nos partenaires pour cet atelier qui a été organisé dans le cadre du projet PaluTrack, financé par la Gates Foundation. #eSanté #Paludisme #Surveillance #Gouvernance #Souveraineté

Epimed IA. Uma nova etapa para a terapia intensiva. Ontem apresentamos oficialmente a Epimed IA, em um evento que reuniu centenas de clientes e profissionais de saúde, presencialmente e on-line. Foi uma oportunidade especial para compartilhar o resultado de anos de desenvolvimento e agradecer a confiança de todos que participaram. A Epimed IA representa uma nova geração de inteligência artificial, integrada ao funcionamento das UTIs, capaz de compreender o contexto clínico, interpretar informações e participar ativamente dos processos de trabalho, ao lado das equipes assistenciais. Apresentamos três agentes que atuam de forma integrada: - Epimed Data: automatiza a coleta de informações clínicas dos prontuários eletrônicos e outros sistemas, realizando seu registro no Epimed Monitor e reduzindo o trabalho manual das equipes. - Epimed Care: apoia a coordenação das rotinas assistenciais, acompanhando visitas clínicas, passagens de plantão, tarefas e pendências, contribuindo para a continuidade e a execução do cuidado. - Epimed Advisor: analisa continuamente indicadores clínicos, operacionais e dados de benchmarking para identificar e priorizar oportunidades de melhoria do desempenho das UTIs, apoiando as decisões dos gestores. Agora começa uma etapa que nos entusiasma especialmente, trabalhar com os hospitais interessados na implantação dessa tecnologia. A manifestação de interesse está aberta até 23 de novembro, com condições especiais de adesão, inclusive para leitos destinados ao SUS. O link para conhecer o projeto e manifestar interesse está no primeiro comentário.

A few weeks ago, we spent three days at Dentex 2026 in Brussels. 🦷 We met up with dentists, practice owners and receptionists from Belgium and beyond. Some were familiar faces, many were new. What really stood out were the conversations. Every practice has its own way of doing things but a whole host of the day to day problems are very similar. We took loads of those stories home with us. Add good company, plenty of coffee and a spinning wheel and you've got three absolutely wonderful days. A big thank you to Thomas V. for representing TurnUp in Brussels, and to everyone who stopped by. We had a great time. Until next time! #Dentex #Dentex2026 #Dentistry #Brussels #TurnUp